Evolving Role of Immunotherapy in Metastatic Castration Refractory Prostate Cancer

Immunotherapies have shown remarkable success in the treatment of multiple cancer types; however, despite encouraging preclinical activity, registration trials of immunotherapy in prostate cancer have largely been unsuccessful. Sipuleucel-T remains the only approved immunotherapy for the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rathi, Nityam, McFarland, Taylor Ryan, Nussenzveig, Roberto, Agarwal, Neeraj, Swami, Umang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Leading Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932934/
https://www.ncbi.nlm.nih.gov/pubmed/33369720
http://dx.doi.org/10.1007/s40265-020-01456-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932934/
https://www.ncbi.nlm.nih.gov/pubmed/33369720
http://dx.doi.org/10.1007/s40265-020-01456-z

Ejemplares similares